Literature DB >> 22778460

Successful treatment of two refractory venous stasis ulcers treated with a novel poly-N-acetyl glucosamine-derived membrane.

Erik Alberto Maus1.   

Abstract

Standard of care for venous leg ulcers (VLUs) consists of the application of compression bandages or stockings and of local moist wound care. While the majority of patients heal with the above mentioned treatments some ulcers become refractory to treatment causing significant disability and costs. The authors present the observation made on two patients with VLUs who had failed to respond to a comprehensive state of the art wound care approach for 11 and 3 years respectively. Both patients were treated with a poly-N-acetyl glucosamine-derived membrane (pGlcNAc) (Talymed, Marine Polymer Technologies, Danvers, Massachusetts, USA) in addition to compression bandaging. Both patients healed within 6 weeks of the first application of pG1cNAc. The authors present two cases of VLUs that had been considered non-healable that were successfully treated in a very short period of time with the application of a novel technology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22778460      PMCID: PMC3417013          DOI: 10.1136/bcr.03.2012.6091

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

Review 1.  Chronic venous disease.

Authors:  John J Bergan; Geert W Schmid-Schönbein; Philip D Coleridge Smith; Andrew N Nicolaides; Michel R Boisseau; Bo Eklof
Journal:  N Engl J Med       Date:  2006-08-03       Impact factor: 91.245

2.  A randomized, investigator-blinded, controlled pilot study to evaluate the safety and efficacy of a poly-N-acetyl glucosamine-derived membrane material in patients with venous leg ulcers.

Authors:  Teresa J Kelechi; Martina Mueller; Cheryl S Hankin; Amy Bronstone; John Samies; Phyllis A Bonham
Journal:  J Am Acad Dermatol       Date:  2011-05-26       Impact factor: 11.527

3.  Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group.

Authors:  V Falanga; D Margolis; O Alvarez; M Auletta; F Maggiacomo; M Altman; J Jensen; M Sabolinski; J Hardin-Young
Journal:  Arch Dermatol       Date:  1998-03

4.  Poly-N-acetyl glucosamine nanofibers regulate endothelial cell movement and angiogenesis: dependency on integrin activation of Ets1.

Authors:  John N Vournakis; Juanita Eldridge; Marina Demcheva; Robin C Muise-Helmericks
Journal:  J Vasc Res       Date:  2007-12-19       Impact factor: 1.934

5.  Poly-N-acetyl glucosamine nanofibers: a new bioactive material to enhance diabetic wound healing by cell migration and angiogenesis.

Authors:  Saja Sandra Scherer; Giorgio Pietramaggiori; Jasmine Matthews; Samuel Perry; Anke Assmann; Adelaide Carothers; Marina Demcheva; Robin C Muise-Helmericks; Arun Seth; John N Vournakis; Robert C Valeri; Thomas H Fischer; Herbert B Hechtman; Dennis P Orgill
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

Review 6.  Compression for venous leg ulcers.

Authors:  Susan O'Meara; Nicky A Cullum; E Andrea Nelson
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21
  6 in total
  1 in total

1.  pGlcNAc Nanofiber Treatment of Cutaneous Wounds Stimulate Increased Tensile Strength and Reduced Scarring via Activation of Akt1.

Authors:  Haley Buff Lindner; Lloyd McPherson Felmly; Marina Demcheva; Arun Seth; Russell Norris; Amy D Bradshaw; John Vournakis; Robin C Muise-Helmericks
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.